Forchronic, S.L. 

New natural nutraceutical products and food supplements with therapeutical activity in cancer and immune disorders.

OWNER

Enrique Sainz (See Profile)


Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

SPAIN


Patented Technology by Forchronic in area of precision nutrition

Estimated value market 2026: 734.60 BN $

First product finished, focused on pathology with maximun prevalence, validated in clinical trials and license in talks

Investment of more than € 4 Million in the development of technological solutions focused on personalized nutrition

More of 50 scientific proffesionals, researchers and clinical profiles involved in the development of our technologies

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 29th October

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar